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Transforming growth factor-b (TGF-b), Smads, and the
cyclin-dependent kinase (cdk) inhibitor p21WAF1 are
important in the pathogenesis of diabetic tubular
hypertrophy. Phosphoinositide 3 kinase (PI3K)/Akt kinase
activity is increased in diabetic glomerular hypertrophy. Thus,
we studied the role of PI3K in high glucose (30 mM)-induced
p21WAF1, Smad2/3, and cell cycle-dependent hypertrophy in
LLC-PK1 cells. We found that high glucose time-dependently
(1–48 h) increased PI3K/Akt kinase activity. LY294002 (a PI3K
inhibitor) attenuated high glucose-induced cell cycle-
dependent (G0/G1 phase) hypertrophy at 72 h while
attenuating high glucose-induced p21WAF1 gene
transcription and protein expression at 36–48 h. LY294002
also attenuated high glucose-induced binding of p21WAF1 to
the cyclin E/cdk2 complex, whereas attenuating high
glucose-induced TGF-b bioactivity, Smad2/3 phosphorylation,
and Smad2/3 DNA-binding activity at 36–48 h. We concluded
that PI3K is required for high glucose-induced cell
cycle-dependent hypertrophy, p21WAF1 transcription and
expression, p21WAF1 binding to the cyclin E/cdk2 complex,
TGF-b bioactivity, and Smad2/3 activity in LLC-PK1 cells.
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Diabetic nephropathy is characterized by cell cycle-dependent
glomerular and tubular hypertrophy and cell cycle derange-
ments.1–3 Tubular damage is as important as glomerulopathy
in diabetic nephropathy.1,4 Transforming growth factor-b
(TGF-b), Smads, and the cyclin-dependent kinase (cdk)
inhibitor p21WAF1 are important in the pathogenesis of
diabetic tubular hypertrophy.1–3
Glomerular p21WAF1 is required for diabetic glomerular
hypertrophy5 in mice, whereas high glucose increases
p21WAF1 expression in mesangial cells.6 In contrast, the role
of p21WAF1 in the proximal tubule is shown by the finding
that p21WAF1 causes hypertrophy in the proximal tubule-like
LLC-PK1 cells.7 Because high glucose induces hypertrophy in
LLC-PK1 cells,8 we wish to study the regulation of p21WAF1 in
high glucose-cultured LLC-PK1 cells.
Apart from p21WAF1, phosphoinositide 3-kinase
(PI3K), which activates Akt/protein kinase B by phosphory-
lation on Thr308 and Ser473, is important in the regulation
of cell growth and cell cycles.9,10 Thus, cortical PI3K activity
is increased,11 whereas glomerular PI3K is activated
in diabetic glomerular hypertrophy in mice.12 More-
over, high glucose-induced hypertrophy is dependent
on PI3K in mesangial cells.12 However, the role of PI3K in
the proximal tubule in diabetic nephropathy (DN) remains
unknown.
Therefore, we studied the role of PI3K in high glucose-
induced p21WAF1 Smad2/3 and cell cycle-dependent hyper-
trophy in LLC-PK1 cells.
RESULTS
High glucose time-dependently activates PI3 kinase and Akt
kinase
PI3K activity was assessed by a competitive enzyme-linked
immunosorbent-based assay for p85-immunoprecipitated
PI3K. Akt kinase activity was assessed using the Akt kinase
assay kit. High glucose (30 mM) time-dependently (1–48 h)
increased PI3K activity (Figure 1). However, mannitol
(24.5 mM) did not affect PI3K activity at 48 h. Moreover,
high glucose time-dependently (1–48 h) increased Akt kinase
activity (Figure 2).
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High glucose-induced cell cycle-dependent hypertrophy
is dependent on PI3K in LLC-PK1 cells
Cell hypertrophy was assessed by protein/DNA ratio and 3H-
leucine incorporation, whereas cell cycles were assessed by
flow cytometry. As shown in Figure 3a, high glucose (30 mM)
increased cell hypertrophy by 54%, a degree similar to two
previous studies (40–42%).13,14 LY294002 attenuated high
glucose (30 mM)-induced protein/DNA ratio at 72 h (Figure
3a). Moreover, LY294002 and dominant-negative p85 plas-
mid attenuated high glucose-induced 3H-leucine incorpora-
tion at 72 h (Figure 3b).
High glucose also increased the percentage of the cells in
the G0/G1 phase of the cell cycle by 30% (Figure 3c). This
degree of change is similar to a previous study in high
glucose-cultured madin-darby canine kidney (MDCK) cells
(22%)15 and another study in angiotensin II-cultured human
proximal tubular cells (30%).16 Moreover, LY294002 attenu-
ated high glucose-induced arrest of the cells in the G0/G1
phase of the cell cycle at 48 h (Figure 3c).
High glucose-induced p21WAF1 gene transcription and pro-
tein expression are dependent on PI3K
Protein expression of p21WAF1 was measured by immuno-
blotting. Transcriptional activity of p21WAF1 was assessed
by luciferase promoter activity assay of the p21Psma plasmid.
Thus, high glucose (30 mM) and wild-type p85 (pSRa-wtp85)
increased p21WAF1 protein expression, whereas LY294002
and dominant-negative p85 (pSRa-Dp85) attenuated high
glucose (30 mM)-induced p21WAF1 protein expression at
48 h (Figure 4). However, wild-type p85 did not further
increase p21WAF1 protein expression compared with 30 mM
of glucose alone. Moreover, LY294002 attenuated high
glucose-induced p21WAF1 gene transcriptional activity at
36 h (Figure 5).
High glucose decreased stabilities of p21WAF1 mRNA and
p21WAF1 protein
Expression of p21WAF1 mRNA was measured by real-time
reverse transcriptase-polymerase chain reaction (RT-PCR).
As shown in Figure 6, high glucose (30 mM) increased
p21WAF1 mRNA expression (twofold). Stability of p21WAF1
mRNA was measured by the decay of p21WAF1 mRNA after
actinomycin D by real-time RT-PCR. Stability of p21WAF1
protein was measured by the decay of p21WAF1 protein after
cycloheximide. High glucose (30 mM) decreased stability of
both p21WAF1 mRNA (Figure 6a) and p21WAF1 protein
(Figure 6b).
High glucose-induced p21WAF1/cyclin E/cdk2 complex is
dependent on PI3K
Cells are arrested by p21WAF1 in the G0/G1 phase of the
cell cycle by binding to cyclin E/cdk2 complex.17,18 Thus,
we studied the interaction between p21WAF1 cyclin E and
cdk2 by immunoprecipitation and immunoblotting.
As shown in Figure 7, high glucose (30 mM) did not change
the amount of cdk2 in the multimeric cyclin E-cdk2 complex.
In contrast, high glucose increased the binding of p21WAF1 to
the cyclin E/cdk2 complex at 48 h. Moreover, LY294002
attenuated the binding of p21WAF1 to the cyclin E/cdk2
complex at 48 h.
High glucose-induced TGF-b bioactivity and Smad2/3 activity
are dependent on PI3K
The TGF-b/Smad pathway is a known activator of the
promoter of p21WAF1 gene.19,20 Thus, we assessed the role of
PI3K in modulating the TGF-b/Smad pathway. As shown in
Figure 8b, high glucose (30 mM) induced a 1.45-fold increase
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Figure 1 | Time-dependent effects of high glucose on PI3 kinase
activity in LLC-PK1 cells. Cells were treated with either 5.5 mM
glucose (open bar, lane 1) or 30 mM glucose (gray bars, lanes 3–9) for
1–72 h. Cells treated with 24.5 mM mannitol (gray bar, lane 2) for 48 h
were used as osmotic controls. Immunoprecipitated PI3K was used in
a competitive enzyme-linked immunosorbent-based assay as
described in Materials and Methods. Note that high glucose (30 mM),
but not mannitol (24.5 mM), time-dependently increased PI3 kinase
activity at 1–48 h. Data were expressed as the mean7s.e.m. of three
independent experiments. *Po0.05 versus lane 1, **Po0.01 versus
lane 1.
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Figure 2 | Time-dependent effects of high glucose on Akt kinase
activity in LLC-PK1 cells. Cells were treated with 5.5 mM glucose
(open bar, lane 1) or 30 mM glucose (gray bars) for 0.5–72 h. Akt kinase
activity was assayed by measuring Akt-associated GSK3ab using the
Akt kinase assay kit. Immunoblotting (IB) and immunoprecipitation
(IP) were performed as described in Materials and Methods. Note that
high glucose (30 mM) time-dependently increased Akt kinase activity
at 1–48 h. The intensity of p-GSK3ab was normalized to that of Akt.
Data were expressed as the mean7s.e.m. of three independent
experiments. *Po0.05, **Po0.01 versus lane 1.
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in Smad 2/3 phosphorylation, a degree similar to two
previous studies (1.23- to 1.6-fold).21,22 Moreover, LY294002
attenuated high glucose (30 mM)-induced TGF-b bioactivity
(Figure 8a), Smad2/3 phosphorylation (Figure 8b), and
Smad2/3 DNA binding activity (Figure 8c). Note that
although anti-Smad2/3 antibody attenuated the putative
Smad band, there was no supershifted band, which is similar
to two previous studies in proximal tubular cells23 and
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Figure 3 | Role of PI3 kinase in high glucose-induced cell cycle-dependent cell hypertrophy in LLC-PK1 cells. Cells were treated with
either 5.5 mM glucose (open bars) or 30 mM glucose (gray bars). Cell hypertrophy was assessed by protein/DNA ratio and 3H-leucine
incorporation. (a) LY294002 (5 mM, pretreated for 30 min, lane 4) attenuated high glucose (30 mM)-induced protein/DNA ratio at 72 h. (b) High
glucose (30 mM, lane 6), but not mannitol (M, 24.5 mM, lane 2), increased 3H-leucine incorporation. Cells were transiently transfected with empty
vector (pSRa), or dominant-negative (pSRa-Dp85) p85 plasmids. Note that LY294002 (lane 7) and dominant-negative p85 plasmid (lane 9)
attenuated high glucose-induced 3H-leucine incorporation at 72 h. (c) Cell cycle was assessed by flow cytometry as H-leucine incorporation
described in Materials and Methods. Note that high glucose (30 mM), but not mannitol (24.5 mM), induced arrest of the cells in the G0/G1 phase
of the cell cycle, whereas LY294002 (5 mM, pretreated for 30 min) attenuated high glucose-induced cell cycle arrest at 48 h. This graph of cell
cycle distribution is representative of three independent experiments. Data were expressed as the mean7s.e.m. of three independent
experiments. *Po0.05 versus 5.5 mM of glucose alone. #Po0.05 versus 30 mM of glucose alone.
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Figure 4 | Role of PI3 kinase in high glucose-induced p21WAF1 protein expression in LLC-PK1 cells. Cells were treated with either 5.5 mM
(open bar, lane 1) or 30 mM (gray bars). p21WAF1 protein expression was measured by immunoblotting. (a) High glucose (30 mM, lane 3), but not
mannitol (24.5 mM, lane 2), induced p21WAF1 protein expression, whereas LY294002 (2.5–5 mM, pretreated for 30 min, lanes 4–5) attenuated high
glucose-induced p21WAF1 protein expression at 48 h. (b) Cells were transiently transfected with empty vector (pSRa), wild-type (pSRa-wtp85) or
dominant-negative (pSRa-Dp85) p85 plasmids. High glucose (lane 2) and wild-type p85 (lane 3) increased p21WAF1 protein expression, whereas
dominant-negative p85 (lane 6), but not wild-type p85 (lane 4), attenuated high glucose-induced p21WAF1 protein expression at 48 h. However,
wild-type p85 (lane 4) did not further increase p21WAF1 protein expression compared with lane 2. The intensity of p21WAF1 was normalized to
that of a-tubulin. Data were expressed as the mean7s.e.m. of four independent experiments. *Po0.05 versus 5.5 mM of glucose alone;
#Po0.05, ##Po0.01 versus 30 mM of glucose alone.
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mesangial cells.24 This observation indicates that anti-Smad2/
3 antibody may mask the DNA-binding domain of Smad
proteins in proximal tubular cells.
Because p21WAF1 promoter contains no Smad-binding
element while Sp1 physically interacts with Smad2/3,25
we further studied protein–protein interaction between
Smad2/3 and Sp1 by immunoprecipitation.23 As shown in
Figure 9, high glucose increased protein–protein interaction
between Smad2/3 and Sp1, which was attenuated by
LY294002.
DISCUSSION
In this study, we found that PI3K is required for high
glucose-induced cell cycle-dependent cell hypertrophy in
LLC-PK1 cells. Moreover, PI3K is required for high glucose-
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Figure 5 | Role of PI3 kinase in high glucose-induced p21WAF1
gene transcription in LLC-PK1 cells. p21WAF1 gene transcriptional
activity was studied by luciferase promoter activity assay of the
p21Psma plasmid as described in Materials and Methods. High
glucose (30 mM, lane 3), but not mannitol (24.5 mM, lane 2), induced
p21WAF1 gene transcriptional activity, whereas LY294002 (5 mM,
pretreated for 30 min, lane 3) attenuated high glucose-induced
p21WAF1 gene transcriptional activity at 36 h. *Po0.05 versus lane 1.
##Po0.01 versus lane 3.
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Figure 6 | Stability of p21WAF1 mRNA and p21WAF1 protein in LLC-PK1 cells. (a) Cells were treated with 5.5 or 30 mM of glucose for 48 h
before adding actinomycin D or cycloheximide. p21WAF1 mRNA stability was measured by the decay of p21WAF1 mRNA after actinomycin D
(5 mM) by real-time RT-PCR in 5.5 mM (open circles) or 30 mM of glucose (closed circles)-treated cells. 18S mRNA was used as an internal control.
Note that high glucose (30 mM) decreased the half-life (t1/2) of p21
WAF1 mRNA from 3 to 1.4 h. (b) p21WAF1 protein stability was measured by the
decay of p21WAF1 protein after cycloheximide (10 mM) by immunoblotting in 5.5 mM (open circles) or 30 mM glucose (closed circles)-treated cells.
Actin was used as an internal control. Note that high glucose (30 mM) decreased the half-life (t1/2) of p21
WAF1 protein from 4 to 1.5 h.
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Figure 7 | Time-dependent effects of high glucose on
protein–protein interaction between p21WAF1 and cyclin E in
LLC-PK1 cells. Cells were treated with either 5.5 mM (open bar,
lane 1) or 30 mM glucose (gray bars). Immunoblotting (IB) and
immunoprecipitation (IP) were performed as described in Materials
and Methods. Note that high glucose (30 mM) did not change the
amount of cdk2 in the multimeric complex. Mannitol (24.5 mM)
decreased protein–protein interaction between p21WAF1 and cyclin E
at 24 h, whereas high glucose (30 mM) increased protein–protein
interaction between p21WAF1 and cyclin E at 48 h. Moreover,
LY294002 (5 mM, pretreated for 30 min) attenuated high
glucose-induced protein–protein interaction between p21WAF1 and
cyclin E at 48 h. The intensity of the upper panels was normalized to
the middle panel. Data were expressed as the mean7s.e.m. of three
independent experiments. *Po0.05, **Po0.01 versus lane 1.
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induced Smad2/3 activation, p21WAF1 transcriptional activa-
tion, and protein expression.
We found that high glucose activates PI3 kinase/Akt in
LLC-PK1 cells. This finding is corroborated by a previous
study showing that high glucose-induced osteopontin is
attenuated by LY294002 in proximal tubular cells.26 Similarly,
a previous study found that high glucose activates PI3K/Akt
in mesangial cells.27
PI3K is also required for high glucose-induced cell cycle-
dependent hypertrophy in LLC-PK1 cells. In contrast, two
previous studies found that PI3K is required for endothelin-
induced hypertrophy in mesangial cells28 and vascular
endothelial growth-factor-induced hypertrophy in proximal
tubular cells.29 Interestingly, endothelin and vascular en-
dothelial growth factor are involved in the pathogenesis of
DN.3
Regulation of p21WAF1 is mediated by transcriptional and
post-transcriptional (e.g. mRNA stability, translation, and
protein stability) pathways.19 Accordingly, we found that
high glucose increased p21WAF1 transcriptional activity (2.7-
fold) while decreasing p21WAF1 mRNA stability. Moreover,
high glucose increased p21WAF1 mRNA expression by twofold
while decreasing p21WAF1 protein stability by 2.7-fold.
Thus, if p21WAF1 protein translation was unchanged,
p21WAF1 protein expression should decrease. Because high
glucose increased p21WAF1 protein expression by 1.9-fold, it is
apparent that high glucose increased p21WAF1 protein
translation. This observation is compatible with the notion
that PI3K regulates both transcription and translation.30
In this study, PI3K overexpression increased p21WAF1
protein expression in cells cultured in 5.5 mM glucose, but
not in 30 mM glucose. Moreover, PI3K is required for high
glucose-induced p21WAF1 transcriptional activity and protein
expression. In contrast, PI3K is required for p21WAF1
transcriptional activity and protein expression in epithelial31
and endothelial cells,32 respectively.
One of the probable mechanisms whereby PI3K induces
p21WAF1 transcriptional activity is by interacting with the
TGF-b/Smad pathway, a known activator of the p21WAF1
gene.19,20 Accordingly, we found that high glucose-induced
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Figure 8 | Role of PI3 kinase in high glucose-induced TGF-b bioactivity and Smad2/3 activation in LLC-PK1 cells. Cells were treated with
either 5.5 mM (open bar, lane 1) or 30 mM of glucose (gray bars). TGF-b bioactivity was assessed by luciferase promoter activity assay of the
p3TP-lux plasmid as described in Materials and Methods. Smad2/3 activation was assessed by phospho-Smad2/3 (p-Smad2/3) protein
expression (immunoblotting) and Smad DNA-binding activity (electrophoretic mobility shift assay). (a) LY294002 (5 mM, pretreated for
30 min) attenuated high glucose-induced TGF-b bioactivity at 36 h. (b) LY294002 (5 mM, pretreated for 30 min) attenuated high
glucose-activated Smad2/3 at 48 h. The intensity of p-Smad2/3 was normalized to that of Smad2/3. (c) LY294002 (5 mM, pretreated for
30 min) attenuated high glucose-induced Smad2/3 DNA binding activity at 36 h. (d) Cold probe (but not scrambled probe) and Smad2/3
antibody (but not control IgG) attenuated the binding of Smad2/3 to the Smad-binding element. Data were expressed as the mean7s.e.m.
of three independent experiments. *Po0.05 versus lane 1. #Po0.05, ##Po0.01 versus 30 mM glucose alone.
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TGF-b bioactivity and Smad2/3 activation are dependent on
PI3K. On the other hand, TGF-b activates both Smad2/3 and
PI3K in the distal tubule-like MDCK cells.33 Moreover, PI3K
is required for TGF-b-activated Smad2/3 in mesangial cells34
and mammary epithelial cells.35
Binding of p21WAF1 to the cyclin E/cdk2 complex
inactivates cdk2 and arrests the cell cycle in the G0/G1 phase,
which is associated with cell hypertrophy.17,18 Accordingly,
we found that high glucose-induced cell hypertrophy is
associated with increased p21WAF1 protein expression,
increased binding of p21WAF1 to the cyclin E/cdk2 complex,
and an arrest of the cells in the G0/G1 phase of the cell cycle.
This finding is corroborated by a previous study showing that
the p21WAF1/cyclin E/cdk2 complex is increased in diabetic
renal hypertrophy in rats.14
In conclusion, high glucose activates the PI3K/Akt path-
way. Moreover, high glucose-induced hypertrophy, Smad2/3
activation, p21WAF1 transcriptional activation and protein
expression, and p21WAF1/cyclin E/cdk2 complex are depen-
dent on PI3K.
MATERIALS AND METHODS
Cell culture and reagents
LLC-PK1 cells were purchased from the American Type Culture
Collection (Manassas, VA, USA). Cells were cultured in Dulbecco’s
modified Eagle’s medium (5.5 mM D-glucose) supplemented with
1% penicillin/streptomycin (Gibco, Grand Island, NY, USA) and
10% fetal bovine serum (Gibco) in a humidified 5% CO2 incubator
at 371C. p21Waf1, cyclin E and actin antibodies were obtained from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Cdk2
antibodies were purchased from Lab Vision Corporation (Fremont,
CA, USA). Smad2/3, Akt, and p-GSK3ab antibodies were purchased
from Cell Signaling Technology (Danvers, MA, USA). Purchase
of p-Smad2/3 antibody was from BioSource International Inc.
(Camarillo, CA, USA). Purchase of a-tubulin antibody was from
Lab Vision Corporation (Fremont, CA, USA). Control rabbit IgG
was purchased from ICN Biochemicals (Costa Mesa, CA,
USA). LY294002 (PI3K inhibitor), H-33258, and other chemicals
were purchased from Sigma Chemical Company (St Louis, MO,
USA).
Plasmids
The p21WAF1 promoter p21Psma was a gift of Dr Xiao-Fan Wang.36
The TGF-b bioactivity reporter p3TP-lux, which contains the
plasminogen activator inhibitor-1 promoter, was a gift of Dr Joan
Massague.37 Other plasmids, including pSRa (empty vector), pSRa-
wt p85 (wild-type p85), and pSRa-Dp85 (dominant-negative p85),
were gifts from Dr Wataru Ogawa.38 Plasmids were transiently
transfected to LLC-PK1 cells with the lipofectAMINE transfection
reagent (Invitrogen Inc., Carlsbad, CA, USA).
Immunoblotting
Briefly, a 30 mg sample of cell lysate was subjected to electrophoresis
on 12% sodium dodecyl sulfate-polyacrylamide gels.39 The samples
were then electroblotted on polyvinylidene difluoride membranes.
After blocking, blots were incubated with antibody in blocking
solution for 1 h followed by two 5-min washes in phosphate-
buffered saline containing 0.1% Tween 20. The membranes were
then incubated with horseradish peroxidase-conjugated secondary
antibodies for 30 min. Enhanced chemiluminescence reagents were
employed to depict the protein bands on membranes.
Real-time RT-PCR
Two micrograms of total RNA extracted by using Trizol method was
used to synthesize cDNA with the reverse transcription system
(Promega Corp., Madison, WI, USA). p21WAF1 gene expression were
analyzed by real-time RT-PCR in triplicate using the SYBR system
based on the real-time detection of accumulated fluorescence (ABI
Prism 7900; Perkin-Elmer, Foster City, CA, USA) as in our previous
study.40 Briefly, 18S ribosomal RNA was used as an internal control.
For p21WAF1 the forward primer was 50-CAGGACTGCGATGCACT
GAT-30 and the reverse primer was 50-ACACGTTCCCAGGCGAA
GT-30. For 18S, the forward primer was: 50-CGAGCCGCCTGGA
TACC-30 and the reverse primer was 50-CAGTTCCGAAAACCAA
CAAAATAGA-30. Amplification was performed with the following
time course: 951C for 10 min, 40 cycles of 941C for 20 s, and 601C
for 1 min. Results are expressed relative to values in the control
group, which were arbitrarily assigned a value of 1.
Cell cycle analysis
Similar to our previous study,41 cells were seeded in a 60-mm dish at
a density of 1 105 cells/dish in Dulbecco’s modified Eagle’s
medium media supplemented with 10% fetal bovine serum 24 h at
371C in 5% CO2 incubator. Cells were scraped and washed twice
with phosphate-buffered saline, fixed with 70% ice-cold ethanol,
followed by the incubation of the freshly prepared nuclear staining
buffer (0.1% Triton X-100 in phosphate-buffered saline, 200 mg/ml
RNase, and 100 mg/ml propidium iodide) for 15 min at 371C. Cell
cycle histograms were generated after analysis of propidium iodide-
stained cells by fluorescence-activated cell sorting with FACScan
(Becton Dickinson, San Jose, CA, USA). For each sample, at least
1 104 events were recorded. Histograms generated by fluorescence-
activated cell sorting were analyzed by the WinCycle Analysis
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Figure 9 | Protein–protein interaction between Smad2/3 and Sp1
in high glucose-treated LLC-PK1 cells. Cells were treated with
either 5.5 mM (open bar, lane 1) or 30 mM of glucose (gray bars).
Sp1-immunoprecipitated (IP) cell lysates were then immunoblotted
(IB) with Smad2/3 antibody. Note that high glucose (lane 2) increased
protein–protein interaction between Smad2/3 and Sp1, which was
attenuated by LY294002 (5 mM, pretreated for 30 min). Data were
expressed as the mean7s.e.m. of three independent experiments.
*Po0.05 versus lane 1. #Po0.05 versus lane 2.
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software (Phoenix Flow Systems, San Diego, CA, USA) to determine
the percentage of cells in each phase (G1, S, and G2/M).
Measurement of cell protein and DNA
Briefly, cells were trypsinized and pelleted, resuspended in 1 ml
buffer (50 mM Na2PO4, pH 7.4), and cells were lysed on ice by
repeated passage through a 27-G needle.13 The lysate was aliquoted
for protein (Bio-Rad protein assay kit, Bio-Rad, Hercules, CA, USA)
and DNA determination. DNA was measured using the fluorescent
compound bisbenzimide H-33258 fluorochrome.
3H-leucine incorporation
Protein/DNA ratio and 3H-leucine incorporation (de novo protein
synthesis) were used to measure cellular hypertrophy.13 Briefly, cells
were seeded in 24-well plates in a density of 5 103 cells/ml in
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine
serum. After attachment of the cells for 24 h, they were treated with
high glucose (30 mM) for 48 h. Then cells were pulsed with 2 mCi
3H-leucine. After further 24-h incubation, cells were washed with
ice-cold phosphate-buffered saline and 5% trichloroacetic acid,
solubilized in 0.5 N NaOH, and counted by a liquid scintillation
counter.
Luciferase promoter activity assay
LLC-PK1 cells were plated into six-well plates at a density of
5 104 cells/well in Dulbecco’s modified Eagle’s medium and grown
for 1 day. Cells were transfected with 0.5mg of plasmid construct
using a standard lipofectAMINE transfection protocol. Briefly, cells
were also transfected with 1 mg of CMV-SPORT-b-galactosidase
(Gibco-BRL, Rockville, MD, USA) to control for transfection
efficiency.40 Five hours after transfection, cells were treated with
either normal or high glucose for the indicated times. Cells were
lysed and luciferase activity was assayed by integrating the total light
emission over 10 s by using the Dynatech ML1000 luminometer.
Luciferase activities were normalized to b-galactosidase activity
performed in triplicate.
PI3K activity assay
This was performed as described in a previous study.42 Briefly,
the anti-p85 (Upstate Biotechnology, Lake Placid, NY, USA)
immunoprecipitated PI3K was used in a competitive enzyme-linked
immunosorbent-based assay (Echelon Biosciences, Salt Lake City,
UT, USA) according to the manufacturer’s instructions. Briefly,
the reaction products were incubated with a phosphatidylinositol
3,4,5-trisphosphate detector protein and then added to a phospha-
tidylinositol 3,4,5-trisphosphate-coated microplate for competitive
binding. A peroxidase-linked secondary detection reagent was used
to detect phosphatidylinositol 3,4,5-trisphosphate detector protein
binding to the plate, and the amount of phosphatidylinositol 3,4,5-
trisphosphate produced was calculated from a standard curve
prepared from known concentrations of lipid product.
Akt kinase activity assay
Akt kinase activity was estimated by using an Akt kinase assay kit
according to the manufacturer’s instructions (Cell Signaling
Technology, Danvers, MA, USA).
Preparation of nuclear extracts
Briefly, 8 106 cells were harvested and suspended in hypotonic
buffer A (10 mM HEPES, pH 7.6, 10 mM KCl, 1 mM DTT, 0.1 mM
EDTA, and 0.5 mM phenylmethylsulfonyl fluoride) for 10 min
on ice and vortexed for 10 s.39 Nuclei were pelleted by centrifugation
at 12 000 g for 5 min. The supernatants containing cytosolic
proteins were collected. A pellet containing nuclei was suspended
in buffer C (20 mM HEPES, pH 7.6, 1 mM EDTA, 1 mM DTT,
0.5 mM phenylmethylsulfonyl fluoride, 25% glycerol, and 0.4 M
NaCl) for 10 min on ice. The supernatants containing nuclei
proteins were collected by centrifugation at 12 000 g for 20 min
and stored at 701C. Protein concentration was determined using
a colorimetric assay by a Bio-Rad assay kit (Bio-Rad, Hercules,
CA, USA).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay was performed as in
our previous study.39 Briefly, Smad-binding element oligonucleo-
tides (50-AGT ATG TCT AGA CTG A-30 and 30-TCA TAC AGA TCT
GAC T-50) were synthesized as the binding element probe.
Scrambled Smad-binding element oligonucleotides (50-AGT ATC
ATA GCG TTG A-30 and 30-TCA TAG TAT CGC AAC T-50) were
also synthesized as a binding competitor. The single-stranded
oligonucleotides were annealed as temperature descended from
951C to room temperature. 32P-labeling of the binding probe
was carried out using T4-polynucleotide kinase (New England
BioLabs, Beverly, MA, USA) and g-32P-ATP (3000 Ci/mmol).
Labeled DNA was separated from the unincorporated radioactivity.
Binding reactions were carried out by adding 10 mg of nuclear
protein to 20 ml of binding buffer and g-32P-ATP labeled
probes. Where indicated, cold competitive oligonucleotides
were included during the preincubation periods. One microgram
of antibody was incubated with the nuclear extract for 30 min
at room temperature before the binding reaction. Samples were
incubated at room temperature for 25 min and fractionated by
electrophoresis. After electrophoresis, gels were transferred to filter
paper, dried, and exposed to X-ray on the Hyperfilm-MP
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) using an
intensifying screen. The results were quantified by a scanning
densitometer.
Immunoprecipitation
This was performed as in our previous study.43 Briefly, proteins
from cells lysed in lysis buffer were incubated with antibodies (Akt,
cyclin E) and protein G plus/protein A agarose suspension
(Calbiochem Co. La Jolla, CA, USA). Binding reactions were for
5 h at 41C with continual rotation. The beads were collected and
washed three times (3 min/wash) with lysis buffer. Bound proteins
were eluted by boiling in 1 laemmli sample buffer, separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and
subjected to immunoblotting.
Statistical analyses
These results were expressed as the mean7s.e.m. Unpaired
Student’s t-tests were used for comparison between two groups.
One-way analysis of variance followed by unpaired t-test was used
for comparison among more than three groups. Po0.05 was
considered statistically significant.
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